Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 10/20 | 0.53 |
| ▸ | CNR2 | P34972 | 9/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.49 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | GPR6 | P46095 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.47 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5904277 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL21759190 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL20835188 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL180290 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL4299443 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL23847917 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL14215885 | 0.90 | CNR1 (0.46) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL8521177 | 0.80 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL31545513 | 0.80 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL19852268 | 0.80 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282743-A1 | METHODS OF SYNTHESIZING CANNABIDIOL, DERIVATIVES THEREOF, AND OTHER PHYTOCANNABINOIDS | CITRACHEM CORP. | 2025-09-11 | — | — | US | disclosed |
| WO-2023147057-A2 | METHODS OF SYNTHESIZING CANNABIDIOL, DERIVATIVES THEREOF, AND OTHER PHYTOCANNABINOIDS | CITRACHEM CORP. (US) | 2023-08-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282743-A1 | METHODS OF SYNTHESIZING CANNABIDIOL, DERIVATIVES THEREOF, AND OTHER PHYTOCANNABINOIDS | CNR2, CNR1, CYP8B1 | CNR1 2/4885CNR2 1/4885OPRM1 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.